Frederico Silva Castelo Branco

<i>In vitro</i> antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19

Carolina Q. Sacramento, Natalia Fintelman‐Rodrigues, Jairo R. Temerozo et al. · Journal of Antimicrobial Chemotherapy · 2021 · 98 citations · Full text

New hydrazides derivatives of isoniazid against Mycobacterium tuberculosis: Higher potency and lower hepatocytotoxicity

Frederico Silva Castelo Branco, E.C.D. Lima, Jorge L. O. Domingos et al. · European Journal of Medicinal Chemistry · 2018 · 41 citations

Pulmonary Tuberculosis, Pharmaceutical Science, Higher Potency +9

The <i>in vitro</i> antiviral activity of the anti-hepatitis C virus (HCV) drugs daclatasvir and sofosbuvir against SARS-CoV-2

Carolina Q. Sacramento, Natalia Fintelman‐Rodrigues, Jairo R. Temerozo et al. · 2020 · 37 citations · Full text

Viral Polymerase Structure, Viral Pathogenesis, Immunology +21

Phenylhydrazides as inhibitors of Leishmania amazonensis arginase and antileishmanial activity

E.C.D. Lima, Frederico Silva Castelo Branco, Claudia do Carmo Maquiaveli et al. · Bioorganic & Medicinal Chemistry · 2019 · 20 citations · Full text

Novel 2-Nitroimidazole and Imidazooxazole Derivatives and their Activity against Trypanosoma cruzi and Mycobacterium tuberculosis

Jéssica V. Faria, Fernanda P.Z. Passos, Paulo H.A. da Costa et al. · Medicinal Chemistry · 2021 · 11 citations